.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Express Scripts
Merck
Harvard Business School
Citi
Cipla
Teva
Dow
Deloitte

Generated: December 14, 2017

DrugPatentWatch Database Preview

CEDAX Drug Profile

« Back to Dashboard

Which patents cover Cedax, and when can generic versions of Cedax launch?

Cedax is a drug marketed by Pernix Therap and is included in two NDAs.

The generic ingredient in CEDAX is ceftibuten dihydrate. Three suppliers are listed for this compound. Additional details are available on the ceftibuten dihydrate profile page.

Summary for CEDAX

Drug patent expirations by year for CEDAX

Pharmacology for CEDAX

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Pernix TherapCEDAXceftibuten dihydrateCAPSULE;ORAL050685-002Dec 20, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Pernix TherapCEDAXceftibuten dihydrateFOR SUSPENSION;ORAL050686-001Dec 20, 1995DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Pernix TherapCEDAXceftibuten dihydrateFOR SUSPENSION;ORAL050686-002Dec 20, 1995DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CEDAX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pernix TherapCEDAXceftibuten dihydrateFOR SUSPENSION;ORAL050686-002Dec 20, 1995► Subscribe► Subscribe
Pernix TherapCEDAXceftibuten dihydrateCAPSULE;ORAL050685-002Dec 20, 1995► Subscribe► Subscribe
Pernix TherapCEDAXceftibuten dihydrateFOR SUSPENSION;ORAL050686-002Dec 20, 1995► Subscribe► Subscribe
Pernix TherapCEDAXceftibuten dihydrateFOR SUSPENSION;ORAL050686-002Dec 20, 1995► Subscribe► Subscribe
Pernix TherapCEDAXceftibuten dihydrateFOR SUSPENSION;ORAL050686-001Dec 20, 1995► Subscribe► Subscribe
Pernix TherapCEDAXceftibuten dihydrateFOR SUSPENSION;ORAL050686-001Dec 20, 1995► Subscribe► Subscribe
Pernix TherapCEDAXceftibuten dihydrateFOR SUSPENSION;ORAL050686-001Dec 20, 1995► Subscribe► Subscribe
Pernix TherapCEDAXceftibuten dihydrateCAPSULE;ORAL050685-002Dec 20, 1995► Subscribe► Subscribe
Pernix TherapCEDAXceftibuten dihydrateCAPSULE;ORAL050685-002Dec 20, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Baxter
McKesson
Argus Health
McKinsey
US Army
Queensland Health
Cipla
Fuji
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot